Measures of functioning using MSQ v2.1 in patients with a history of episodic migraine and treated with galcanezumab or placebo injections in a Phase 2 clinical trial

Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 90f02a0ad5cb6ed9a577a4c00402d6e4ea9539fc
First added on: Feb 08, 2025